Abstract
Aims
To determine the role of gap junctions (GJs) in hypoxic pulmonary vasoconstriction (HPV).
Methods and results
Studies were performed in rat isolated intrapulmonary arteries (IPAs) mounted on a myograph and in anaesthetized rats. Hypoxia induced a biphasic HPV response in IPAs preconstricted with prostaglandin F2α (PGF2α, 3 µM) or 20 mM K+. The GJ inhibitors 18β-glycyrrhetinic acid (18β-GA, 30 µM), heptanol (3.5 mM), or 2-aminoethoxydiphenyl borate (2-APB) (75 µM) had little effect on the transient Phase 1 of HPV, but abolished the sustained Phase 2 which is associated with Ca2+ sensitization. The voltage-dependent Ca2+ channel blocker diltiazem (10 µM) had no effect on HPV, and did not alter the inhibitory action of 18β-GA. Sustained HPV is enhanced by high glucose (15 mM) via potentiation of Ca2+ sensitization, in the presence of high glucose 18β-GA still abolished sustained HPV. Simultaneous measurement of tension and intracellular Ca2+ using Fura PE-3 demonstrated that whilst 18β-GA abolished tension development during sustained HPV, it did not affect the elevation of intracellular Ca2+. Consistent with this, 18β-GA abolished hypoxia-induced phosphorylation of the Rho kinase target MYPT-1. In anaesthetized rats hypoxia caused a biphasic increase in systolic right ventricular pressure. Treatment with oral 18β-GA (25 mg/kg) abolished the sustained component of the hypoxic pressor response.
Conclusion
These results imply that GJs are critically involved in the signalling pathways leading to Rho kinase-dependent Ca2+ sensitization during sustained HPV, but not elevation of intracellular Ca2+, and may explain the dependence of the former on an intact endothelium.
Keywords: Hypoxic pulmonary vasoconstriction, Pulmonary artery, Ca2+ sensitization, Gap junctions, 18β-glycyrrhetinic acid
1. Introduction
Hypoxic pulmonary vasoconstriction (HPV) optimizes pulmonary ventilation–perfusion matching in response to alveolar hypoxia, thereby diverting blood away from poorly ventilated regions of the lung. Despite many years of extensive research, the precise mechanisms underlying HPV remain incompletely resolved.1
In isolated intrapulmonary arteries (IPAs), and some perfused lung preparations, the contractile response to acute hypoxia is typically biphasic, with a rapid transient vasoconstriction (Phase 1) superimposed on a more slowly developing sustained contraction (Phase 2).1–4 The mechanisms of these two phases differ. Phase 1 is associated with a transient elevation in intracellular Ca2+ ([Ca2+]i) involving store-operated Ca2+ entry (SOCE) and Ca2+ influx through L-type voltage-dependent Ca2+ channels (VDCC), whereas the sustained Phase 2 is critically dependent on ryanodine-sensitive Ca2+ stores and RhoA/Rho kinase-dependent Ca2+ sensitization.1,3–6 Intriguingly, both Phase 2 of HPV and the associated Ca2+ sensitization have a yet unexplained strong dependence on an intact endothelium and glycolysis.2,4,7–9
Gap-junction-mediated communication within and between the endothelium and smooth muscle cells (SMCs) is important for the control and co-ordination of normal vascular function. Gap junctions (GJs) are formed of adjacent connexons between cells each comprising six connexins (Cxs); the complete channel allows the passage of electrical current and small signalling molecules.10–12 Vascular tissues including pulmonary artery express Cx37, Cx40, Cx43, and Cx45.11,13 The endothelium couples to smooth muscle via myoendothelial GJs (MEGJs),10,11 which are present in IPAs and probably play an important role in the integration of smooth muscle and endothelial function.13–15
Inhibition of GJs supresses HPV in perfused lungs,16 and it has recently been proposed that the signal for HPV originates at the alveolocapillary level, from which it is propagated through the endothelium to upstream arterioles in a Cx40-dependent manner.17 We have also reported that inhibition of glycolysis abolishes the hypoxia-induced depolarization of pulmonary artery endothelial cells,9 suggesting that GJs might be involved in the transduction pathways underlying the glycolysis and endothelium-dependent sustained Phase 2 of HPV.
The aim of the present study was to test the hypothesis that GJs contribute to local signalling in HPV, in addition to any upstream signal propagation, and to examine their role in the development of the glycolysis- and endothelium-dependent sustained phase of HPV.
2. Methods
2.1. Animals and tissue isolation
This study conforms with the UK Home Office regulations and Directive 2010/63/EU of the European Parliament. Ethical approval was obtained from the relevant committees at King's College London and Institute of Pharmacology and Toxicology of National Academy of Medical Sciences of Ukraine. For isolated tissue studies, adult male Wistar rats (225–275 g) were killed by lethal overdose of pentobarbital (i.p.) and cervical dislocation. The heart and lungs were excised and placed into cold physiological saline solution (PSS; in mM: 118 NaCl, 24 NaHCO3, 1 MgSO4, 0.44 NaH2PO4, 4 KCl, 5.5 glucose, and 1.8 CaCl2).
2.2. Tension and intracellular Ca2+ measurements
Small IPA (150–400 µm in diameter) were dissected free of connective tissue, mounted on a wire myograph (Danish Myo Technology A/S, Aarhus, Denmark) and bathed in PSS gassed with 5% CO2, balance air (pH 7.4) at 37°C. Vessels were stretched and pre-conditioned by stimulation with repeated 2 min exposures to 80 mM K+ PSS (KPSS, equimolar substitution for NaCl) as previously described.2,6,7 Simultaneous measurement of IPA tension and intracellular Ca2+ ([Ca2+]i) was performed using IPA mounted on a modified myograph, and following loading with Fura PE-3-AM (4 µM) for 1 h at 37°C. The myograph was placed on an inverted stage fluorescence microscope (Zeiss UK Ltd) with Fluor objective combined with a double-excitation microfluorimeter (CairnResearch Ltd, Faversham, UK). Tension was recorded simultaneously with light emitted by the artery at 510 nm at excitation wavelengths 340 and 380 nm. The ratio of emission intensities (R340/380) was taken as a measure of smooth muscle [Ca2+]i as described previously.6–8 Tension and R340/380 were recorded using Acquisition Engine software (Cairn Research Ltd).
2.3. Experimental protocols for in vitro studies
As previously described,6–8 IPAs were preconstricted with sufficient PGF2α to produce tension equivalent to 10–15% of that produced by KPSS (typically 3 µM) in order to elicit a full contractile response to hypoxia. In some experiments equivalent pretone was induced with PSS containing 20–25 mM [K+]. Hypoxia was induced by switching from 95% air/5% CO2 to 5% CO2/balance N2, which we have shown to provide a PO2 of 15–20 mmHg during hypoxia and 145–150 mmHg during normoxia in the myograph chamber.3 Consecutive hypoxic challenges, separated by 60 min normoxia, demonstrated highly consistent HPV responses within the same IPA. Tension and changes in [Ca2+]i (R340/380) are expressed as percentages of the maximal responses to contraction to KPSS.
IPA incubated under the same conditions as above were snap frozen and protein extracted for western blot analysis of myosin phosphatase targeting protein (MYPT-1) phosphorylation as previously described.6 Membranes were blocked for 1 h with 5% milk, probed with primary antibody overnight at 4°C (1:1000–1:5000 in 5% milk), followed by application of horseradish peroxidase-conjugated anti-IgG secondary antibody (Sigma, UK) for 1 h at room temperature (1:5000). Membranes were first probed with anti-phospho-MYPT-1 (thr-855; Upstate, UK), stripped for 1 h (Pierce stripping buffer), re-blocked, and re-probed with anti-pan MYPT-1 (Cell Signalling, UK). Data are expressed as ratio phospho/pan MYPT-1 as a percentage of in-gel controls.
2.4. In vivo studies
Experiments were conducted on adult male Wistar rats (230–300 g) divided into control and treatment groups. Plasma concentrations of 18β-GA in rats have been shown to fall rapidly after oral administration, but after ∼12 h become relatively stable for up to 24 h.18 Animals were therefore treated orally with 18β-GA (25 mg/kg) 20 h before experimentation. Surgical anaesthesia was induced by intraperitoneal injection of chloralose–urethane (1:10; 40 mg of urethane per 100 g body weight). Once deep anaesthesia was confirmed, tracheal intubation was performed. The left jugular vein and left common carotid artery were catheterized, and heparin (50 U per 100 g body weight) infused. Catheterization of the right ventricle was performed through the right jugular vein. Right ventricular and carotid artery pressures were recorded with ISOTEC pressure transducers (HSE, Germany) and Chart 5 Pro (ADInstruments Ltd, Australia). Animals were mechanically ventilated with a minute volume of 140 mL/min (Ugo Basile 7025 ventilator), and initial values of parameters recorded for ∼25 min after stabilization. Hypoxia was then induced for 30 min by ventilation with 10% O2 in N2. Animals were euthanized at the end of the experiment by means of intravenous urethane (400 mg/100 g).
2.5. Statistical analysis
Results are expressed as means ± SEM. Statistical analysis was performed using ANOVA with a Holm–Sidak post hoc test or Student's t-test as appropriate (Sigmaplot 12, Systat Software Inc., CA).
2.6. Chemicals
Diltiazem, carbachol, 18β-glycyrrhetinic acid (18β-GA), heptanol, 2-aminoethoxydiphenyl borate (2-APB), and Fura-PE-3/AM were obtained from Sigma-Aldrich UK. All drugs were dissolved in deionized water except 18β-GA, heptanol, and Fura PE-3 AM, which were dissolved in dimethyl sulphoxide (DMSO) to make stock solutions; following final dilution DMSO had no effect on its own.
3. Results
3.1. Effect of GJ inhibitors on HPV in isolated IPA
We examined the effects of three structurally unrelated GJ inhibitors, which are thought to act by different mechanisms, 18β-GA, heptanol, and 2-aminoethoxydiphenyl borate (2-APB)19,20; whilst 2-APB is commonly used as an inhibitor of SOCE,21,22 it is also an effective blocker of GJ, with differential efficacy according to the Cx of which they are formed.19 The synthetic37,43Gap27 GJ inhibitor had inconsistent effects, possibly due to diffusional limitations, and was not pursued.
As previously described, hypoxia elicited a biphasic response in tension in IPA preconstricted with PGF2α (Figure 1). The first phase consisted of a transient contraction, which peaked within 3–5 min of the onset of hypoxia, followed by a relaxation which reached a nadir within 10–15 min. This was followed by a more slowly developing and sustained contraction (Phase 2). Reoxygenation resulted in a rapid return of tension to the initial PGF2α-induced values, and on washing with PSS tension returned to the original baseline.
Figure 1.
HPV in rat isolated IPA, and the effect of preincubation with 18β-GA (30 µM) on the response. (A) Example traces following preconstriction with 3 µM PGF2α and the selective suppression of Phase 2 by 18β-GA; mean data are shown in (B) (n = 10). 18β-GA had the same effect in IPA preconstricted by depolarization with 20 mM [K+] (C, n = 7). Symbols represents the mean ± SE. *P < 0.05, **P < 0.01.
Preincubation with 18β-GA (30 µM) was without effect on Phase 1 of HPV, but strongly suppressed Phase 2 (P < 0.001; Figure 1). The effect of 18β-GA on HPV was independent of the means of preconstriction, as equivalent results were obtained in IPA preconstricted by depolarization with PSS containing 20 mM [K+] (Figure 1). Both heptanol (3.5 mM) and 2-APB (75 μM) also strongly suppressed Phase 2; although both caused a small reduction in Phase 1, this only reached significance for heptanol (Figure 2). A lower concentration of 2-APB (30 μM) reduced Phase 2 at 40 min by only 58 ± 6% (n = 5, P < 0.01).
Figure 2.
The effect of the GJ inhibitors heptanol (3.5 mM (A), n = 6) and 2-APB (75 µM (B), n = 7) on HPV in rat IPA preconstricted with 3 µM PGF2α. Symbols represents the mean ± SE. *P < 0.05, **P < 0.001.
Together these data suggest that GJ are involved in the sustained Phase 2 of HPV, but not the transient Phase 1.
3.2. Effect of 18β-GA on HPV following blockade of L-type Ca2+ channels
Blockade of GJs could potentially affect membrane potential in the smooth muscle. We therefore compared the control HPV response with that following incubation with the L-type VDCC blocker diltiazem (10 µM), and in combination with 18β-GA (30 µM) (Figure 3). As previously reported,3 diltiazem alone had no significant effect on either phase of HPV in this preparation; the reduction in Phase 1 did not reach significance (control: 28.7 ± 2.6% KPSS; diltiazem: 23.4 ± 2.3% KPSS, n = 7, NS). However, addition of 18β-GA to diltiazem strongly suppressed the sustained Phase 2 of HPV (Figure 3). Whilst Phase 1 was now significantly reduced compared with control (P < 0.05), it was not significantly different from that with diltiazem alone (diltiazem + 18β-GA: 18.8 ± 2.7% KPSS, n = 7, NS). These results, which are essentially equivalent to those shown in Figure 1, demonstrate that the contribution of GJs to sustained HPV is independent of VDCC.
Figure 3.
Blockade of VDCC with diltiazem (10 µM) had no significant effect on HPV in rat IPA preconstricted with 3 µM PGF2α (filled circles); 18β-GA (30 µM) had almost identical effects in the presence of diltiazem as in its absence (Figure 1). Symbols represents the mean ± SE, n = 7. *P < 0.05, **P < 0.001.
3.3. Effect of 18β-GA on intracellular Ca2+ concentration during HPV
Hypoxia elicited a biphasic response in [Ca2+]i in IPA preconstricted with 3 µM PGF2α, with a transient increase in [Ca2+]i that mirrored the Phase 1 transient increase in tension (Figure 4). However, as previously reported,7,8,23 whereas tension gradually increased during Phase 2, [Ca2+]i remained stable. Reoxygenation resulted in a rapid return of both tension and [Ca2+]i to the initial PGF2α-induced values. Application of 18β-GA (30 µM) had no effect on hypoxia-induced elevation of [Ca2+]i during either phase of HPV (Figure 4). This suggests that GJs are involved in the mechanisms leading to Ca2+ sensitization during sustained HPV, but not the elevation of [Ca2+]i.
Figure 4.
Simultaneous measurement of tension and [Ca2+]i (expressed as R340/380) during HPV in rat IPA preconstricted with 3 µM PGF2α and following preincubation with 18β-GA (30 µM). 18β-GA abolished the rise in tension Phase 2, but had no effect on [Ca2+]i. Symbols represent the mean ± SE, n = 7. *P < 0.05, **P < 0.01.
3.4. Effect of 18β-GA on HPV in the presence of elevated glucose
We have previously shown that Phase 2 of HPV is selectively potentiated by an increase in extracellular glucose concentration, and suppressed or abolished by reduced glucose; this involves the mechanisms underlying the Phase 2-associated Ca2+ sensitization, as altering glucose had no effect on the hypoxia-induced elevation of [Ca2+]i.7 As our results suggest that GJs are also involved in Ca2+ sensitization during Phase 2, we examined the effects of GJ inhibition on the high glucose-induced potentiation of Phase 2 of HPV. Increasing glucose concentration from 5 to 15 mM had no significant effect on basal tension, pretone elicited by PGF2α, or HPV Phase 1, but Phase 2 was significantly potentiated (Figure 5A). In the presence of 15 mM glucose, 18β-GA (30 µM) again had no effect on Phase 1 but abolished Phase 2 (Figure 5).
Figure 5.
(A) Elevation of the glucose concentration from 5 to 15 mM potentiated Phase 2 of HPV in rat IPA preconstricted with 3 µM PGF2α (filled circles, n = 7, #P < 0.05). In the presence of 15 mM glucose 18β-GA still abolished Phase 2 (filled squares, *P < 0.05, **P < 0.01, comparison with high glucose alone). Symbols represent the mean ± SE; where error bars are not shown, they are smaller than the symbol. (B) In the absence of 18β-GA, MYPT-1 phosphorylation (expressed as % unstimulated) in IPA was increased by preconstriction with PGF2α (P < 0.05) and further increased after 30 min hypoxia (*P < 0.05 PGF2α vs. PGF2α plus hypoxia; n = 10). In the presence of 18β-GA, the increase in MYPT-1 phosphorylation induced by preconstriction with PGF2α was unaltered, but thereafter hypoxia had no further effect (NS, PGF2α vs. PGF2α plus hypoxia; n = 8–9).
This suggests that the mechanisms underlying the potentiating action of high glucose on Phase 2 of HPV are not separate from those inhibited by block of GJs, and strengthens the hypothesis that Ca2+ sensitization during hypoxia requires functional GJs.
3.5. Effect of 18β-GA on MYPT-1 phosphorylation during HPV
Ca2+ sensitization during sustained HPV depends on Rho kinase-dependent phosphorylation of MYPT-1.5,6,26 We therefore examined the effect of 18β-GA on MYPT-1 phosphorylation in IPA preconstricted with PGF2α as above and following 30 min hypoxia. In controls, hypoxia increased the ratio of phosphorylated to total MYPT-1 by ∼30% compared with PGF2α alone (P < 0.05, n = 10). This hypoxia-induced increase was however abolished following treatment with 18β-GA, although the response to preconstriction with PGF2α alone was unaltered by 18β-GA (n = 8–9; Figure 5B). These results further suggest that blockade of GJs with 18β-GA impairs hypoxia-induced Rho kinase-mediated Ca2+ sensitization.
3.6. Effect of 18β-GA on right ventricular pressure in vivo
Basal systolic right ventricular pressure (sRVP) in untreated anaesthetized rats was 28.6 ± 1.1 mmHg and the mean systemic arterial pressure (MAP) was 101.5 ± 5.3 mmHg (n = 7). Induction of hypoxia resulted in a biphasic pressor response (Figure 6). sRVP rose to a peak of ∼44% (12.6 ± 0.8 mmHg, P < 0.001) after 5 ± 1 min, then fell to a nadir of ∼24% (7.2 ± 4.2 mmHg, P < 0.001 vs. peak) before increasing again to ∼38% by 32 min (10.9 ± 0.8 mmHg, P < 0.001 vs. baseline and nadir) (Figure 6). Hypoxia caused a fall in MAP over the first 3 min to 64.8 ± 5.4 mmHg (P < 0.001), which thereafter remained constant throughout the period of hypoxic. All changes in haemodynamics reversed on re-oxygenation after ∼5–10 min.
Figure 6.
Hypoxic pressor response in anaesthetized rats in vivo, and following oral administration of 25 mg/kg 18β-GA. (A) Example traces from a control and a treated animal and (B) mean data. In control animals hypoxia elicited a rapid elevation in sRVP followed by a small but significant decline, after which sRVP rose more slowly towards a sustained plateau (#P < 0.01 between points as shown, n = 7). This sustained component was abolished in 18β-GA-treated animals (n = 5). Symbols represent the mean ± SE, *P < 0.01 (control vs. treated). NS = not significant (P > 0.05).
Following oral administration of 18β-GA (25 mg/kg) 20 h before the study, basal sRVP was reduced compared with controls, though this did not reach significance (26.0 ± 1.4 mmHg, n = 5, NS). Conversely there was significant elevation in MAP (120.5 ± 4.5 mmHg, P < 0.05). The initial elevation of sRVP following induction of hypoxia was reduced to 6.9 ± 4.3 mmHg, though this did not reach significance; however, the sustained component of the hypoxic pressor response was effectively abolished (32 min: 0.9 ± 1.9 mmHg, P < 0.001) (Figure 6). MAP during hypoxia showed no difference between control and treated animals (control: 64.8 ± 5.4 mmHg; 18β-GA: 67.0 ± 8.2 mmHg, NS).
4. Discussion
The key finding of this study is that the sustained Phase 2 of HPV, but not the transient Phase 1, is critically dependent on functioning GJs, and our evidence suggests a hitherto unrecognized role for GJs in hypoxia-induced Ca2+ sensitization. As this dependence was apparent in isolated IPA segments, it must be localized to the artery wall and independent of any longitudinal signal propagation from downstream regions of the pulmonary vascular tree.
The biphasic nature of HPV has been recognized for many years, and the initial Phase 1 constriction differs mechanistically from that during the sustained Phase 2.1 Although both phases are associated with an elevation of smooth muscle [Ca2+]i, this is very small in Phase 2 and critically dependent on release from ryanodine-sensitive stores, with a reduced or absent dependence on Ca2+ entry.3,4,25 In particular, and in contrast to Phase 1, tension development during Phase 2 is strongly dependent on the endothelium and Rho kinase-mediated Ca2+ sensitization.4–6,8,23
Whilst this biphasic response is most clearly demonstrated in isolated small IPA,2,4,8,26 it is occasionally apparent in perfused lung preparations and in vivo where the hypoxic challenge is prolonged for more than 20 min.1,27,28 However, the majority of studies on HPV, in whatever preparation, utilize shorter hypoxic challenges of up to 15 min, and are thus effectively only relevant to Phase 1.1,25 Whilst the relative importance of the two phases for acute ventilation–perfusion matching is a subject of debate, the sustained Phase 2 is more relevant to Group 3 pulmonary hypertension with which it shares some common features, specifically a key role for Rho kinase-mediated Ca2+ sensitization.24
As our studies were designed to investigate a role for GJs in local signalling in the absence of signal propagation from remote regions of the pulmonary vasculature, the key experiments were methodologically constrained to small, endothelium-intact segments of IPA. This prevented a molecular approach as incubation of such preparations for sufficient time to allow transfection with, e.g. siRNAs causes significant changes in function (e.g. ref. 29 and own observations). It is also notoriously difficult to induce HPV in isolated mouse IPA, obviating use of GM models.1 We therefore utilized a pharmacological approach with three GJ inhibitors that are believed to act via different mechanisms, 18β-GA, heptanol, and 2-APB. All three demonstrated a similar profile, with strong suppression of HPV Phase 2 and little or no effect on Phase 1 (Figures 1 and 2). Notably, the hypoxic pressor response in vivo also showed a biphasic response, and treatment with 18β-GA similarly abolished the sustained component of HPV but not the initial transient (Figure 6).
18β-GA and heptanol are widely used as GJ inhibitors in vascular tissues.19,30–32 18β-GA is an triterpenoid saponin that disrupts GP plaques by affecting the structural integrity, distribution, and phosphorylation of connexons.19,32 The long-chain alcohol heptanol causes selective disruption at the GJ–lipid interface by intercalating in the lipid bilayer and thus effectively gating GJ channels closed.19,30–32 The mechanism of 2-APB is less clear, but it is recognized as a potent blocker of GJs with a much greater efficacy against Cx40 compared with Cx43.19,20 It is commonly used as an inhibitor of IP3 receptors (which do not play a major role in HPV1), and SOCE,21,22 although notably it is reported that 75 μM 2-APB only inhibits SOCE in SMCs isolated from IPA by ∼40%.33
Whilst SOCE has been implicated in HPV, the evidence is largely restricted to Phase 1 and studies in isolated PASMCs.1,3,34 SOCE is highly sensitive to La3+, and in IPA 1 μM La3+ abolished thapsigargin-induced SOCE and suppressed Phase 1 of HPV3,22; 10 μM La3+ also suppressed the acute hypoxic pressor response in perfused lungs.34 However during Phase 2 of HPV in IPA, 1 μM La3+ was without effect on the elevation of either tension or [Ca2+]i, and La3+ only caused partial suppression at 100 μM, suggesting that SOCE plays a limited role during this phase.3 Notably, at concentrations of 100 μM and above La3+ blocks Cx43-containing GJs.35 In the light of this, and as the effect of 2-APB on HPV showed a similar profile to that of 18β-GA and heptanol with a strong and selective block of Phase 2, it is reasonable to suggest that its actions here are mediated by its established ability to block GJs.19,20
Inhibitors of GJs, including 18β-GA and Cx mimetic inhibitory peptides (Gap27), have been reported to elevate systemic blood pressure in vivo, as observed here. This has been ascribed to inhibition of EDHF-dependent vasorelaxation and/or interference with the renin–angiotensin system.31,36 In contrast, GJ inhibitors in vitro generally induce vasorelaxation or attenuation of constriction, due to smooth muscle hyperpolarization, inhibition of Ca2+ entry, and a consequent fall in [Ca2+]i.31,32,37 As HPV has been associated with hypoxia-induced Ca2+ entry,1,3,27 it is feasible that GJ inhibition could be suppressing Phase 2 in a similar fashion. However, as previously reported3 block of voltage gated L-type Ca2+ channels had no effect on either phase of HPV in this preparation, and 18β-GA still selectively abolished Phase 2 (Figure 5). Moreover, whilst 18β-GA strongly inhibited tension development during Phase 2, it did not affect the hypoxia-induced elevation of [Ca2+]i (Figure 4). This implies that inhibition of GJs is suppressing hypoxia-induced Ca2+ sensitization.
Phase 2 of HPV involves Rho kinase-mediated Ca2+ sensitization, which is endothelium- and glucose dependent.1,5,7,8 Endothelial denudation or removal of glucose abolishes Phase 2 tension development, whilst high glucose potentiates it, in all cases without affecting the associated elevation of [Ca2+]i; notably, high glucose cannot restore HPV in the absence of endothelium.5–8 If functioning GJs are required for hypoxia-induced Ca2+ sensitization, it would be predicted that high glucose would have no effect following GJ blockade with 18β-GA, and this is what was observed (Figure 5A). Moreover, 18β-GA abolished hypoxia-induced phosphorylation of MYPT-1, the target for Rho kinase and a key regulator of Ca2+ sensitivity (Figure 5B).
Our results are consistent with a hitherto unrecognized role for GJs in mediating hypoxia-induced and Rho kinase-dependent Ca2+ sensitization during HPV, which could underlie the so far unexplained dependence of Phase 2 in isolated arteries on an intact endothelium. It has been hypothesized that hypoxia causes release of an endothelium-derived constricting factor, but no such factor with the requisite characteristics has been positively identified; whilst endothelin 1 and others may play a role in HPV, possibly by providing the endogenous equivalent of pretone, they have been excluded as the mediator of Phase 2 Ca2+ sensitization.1,38,39 MEGJs allow direct passage of small signalling molecules up to ∼1.2 kDa.12 Intriguingly, Gairhe et al.40 have recently shown that serotonin synthesized in pulmonary vascular endothelial cells passes through MEGJs to modify smooth muscle differentiation, and binding of intracellular serotonin to RhoA (serotonylation) has been associated with the increased smooth muscle RhoA/Rho kinase activity observed in pulmonary hypertension.41
Blockade of MEGJs has been reported to inhibit contraction of IPA to exogenous serotonin and other agonists by preventing transfer of reactive oxygen species (ROS), most likely superoxide anion.13 This is interesting because of strong evidence that ROS comprise the key mediator of HPV1,24,42 and activate Rho kinase.43,44 Diacylglycerol (DAG) is another small signalling molecule implicated in HPV. Although interest has focussed on its activation of TRPC6 channels during the acute phase,27,45 inhibition of phosphatidylcholine-specific phospholipase C, potentially the source of DAG during hypoxia, is reported to selectively supress sustained HPV.26,46
GJs between endothelial cells allow longitudinal propagation of electrical signals along small vessels. A recent study by Wang et al.17 suggests that retrograde propagation via Cx40-containing GJs between endothelial cells couples oxygen sensing in alveolar capillaries to contraction of upstream pulmonary arterioles, and may thus be a critical requirement for HPV. Such a mechanism is clearly not applicable to the short segments of IPA used in the current study. It also seems unlikely that Cx40 is critically involved in the responses we describe, as unlike Cx43 and most others, Cx40 is effectively completely blocked by 20 μM 2-APB,20 whereas in our hands 30 μM 2-APB only caused partial inhibition of Phase 2. In any event, electrotonic coupling is unlikely to play a role in HPV of isolated IPA, as we have previously demonstrated that this is essentially unaltered following near-maximal depolarization with 80 mM [K+].3 However, our studies do not rule out a role for longitudinal propagation in HPV in the intact lung, as proposed by Wang et al.17
In conclusion, our results suggest that GJs, probably MEGJs, play a critical and previously unsuspected role in sustained HPV by facilitating hypoxia-induced Ca2+ sensitization. This is independent of any role in longitudinal signal propagation as it is apparent in isolated IPA segments. Whilst the GJ inhibitors utilized also have non-junctional actions,20,37 their disparate modi operandi yet identical actions on HPV, with little effect on Phase 1 but robust inhibition of Phase 2, strongly suggests that the latter is indeed due to block of GJs. The mechanism however remains unclear, but is likely to involve transfer of a small signalling molecule such as serotonin or superoxide between endothelium and smooth muscle rather than electrical coupling.
Funding
This work was supported by a Physiological Society Junior Fellowship Grant (IVK); Royal Society International Travel Grant for Collaboration (IVK); and the Wellcome Trust (grant #087776, JPTW & PIA).
Acknowledgments
Conflict of interest: none declared.
References
- 1.Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012;92:367–520. doi: 10.1152/physrev.00041.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Leach RM, Robertson TP, Twort CH, Ward JP. Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Am J Physiol Lung Cell Mol Physiol. 1994;266:L223–L231. doi: 10.1152/ajplung.1994.266.3.L223. [DOI] [PubMed] [Google Scholar]
- 3.Robertson TP, Hague D, Aaronson PI, Ward JP. Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat. J Physiol. 2000;525:669–680. doi: 10.1111/j.1469-7793.2000.t01-1-00669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dipp M, Nye PC, Evans AM. Hypoxic release of calcium from the sarcoplasmic reticulum of pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2001;281:L318–L325. doi: 10.1152/ajplung.2001.281.2.L318. [DOI] [PubMed] [Google Scholar]
- 5.Robertson TP, Dipp M, Ward JP, Aaronson PI, Evans AM. Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol. 2000;131:5–9. doi: 10.1038/sj.bjp.0703537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Knock GA, Snetkov VA, Shaifta Y, Drndarski S, Ward JP, Aaronson PI. Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery. Cardiovasc Res. 2008;80:453–462. doi: 10.1093/cvr/cvn209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Leach RM, Hill HM, Snetkov VA, Robertson TP, Ward JP. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor. J Physiol. 2001;536:211–224. doi: 10.1111/j.1469-7793.2001.00211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Robertson TP, Aaronson PI, Ward JP. Ca2+ sensitization during sustained hypoxic pulmonary vasoconstriction is endothelium dependent. Am J Physiol Lung Cell Mol Physiol. 2003;284:L1121–L1126. doi: 10.1152/ajplung.00422.2002. [DOI] [PubMed] [Google Scholar]
- 9.Soloviev AI, Bondarenko AI, Kizub IV. Selective glycolysis blockade in guinea pig pulmonary artery and aorta reverses contractile and electrical responses to acute hypoxia. Vascul Pharmacol. 2012;57:119–123. doi: 10.1016/j.vph.2012.06.001. [DOI] [PubMed] [Google Scholar]
- 10.Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal. 2009;11:251–266. doi: 10.1089/ars.2008.2117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal. 2009;11:267–282. doi: 10.1089/ars.2008.2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003;83:1359–1400. doi: 10.1152/physrev.00007.2003. [DOI] [PubMed] [Google Scholar]
- 13.Billaud M, Marthan R, Savineau JP, Guibert C. Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications. PloS one. 2009;4:e6432. doi: 10.1371/journal.pone.0006432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Davies P, Burke G, Reid L. The structure of the wall of the rat intraacinar pulmonary artery: an electron microscopic study of microdissected preparations. Microvasc Res. 1986;32:50–63. doi: 10.1016/0026-2862(86)90043-9. [DOI] [PubMed] [Google Scholar]
- 15.Billaud M, Dahan D, Marthan R, Savineau JP, Guibert C. Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension. Respir Res. 2011;12:30. doi: 10.1186/1465-9921-12-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Morio Y, Carter EP, Oka M, McMurtry IF. EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs. Am J Physiol Heart Circ Physiol. 2003;284:H1762–H1770. doi: 10.1152/ajpheart.00831.2002. [DOI] [PubMed] [Google Scholar]
- 17.Wang L, Yin J, Nickles HT, Ranke H, Tabuchi A, Hoffmann J, et al. Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction. J Clin Invest. 2012;122:4218–4230. doi: 10.1172/JCI59176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sun HY, Li Q, Chen W, Geng LL, Li X, Chen XH, et al. Pharmacokinetic analysis of alpha and beta epimers of glycyrrhetinic acid in rat plasma: differences in singly and combined administrations. Yao Xue Xue Bao. 2012;47:94–100. [PubMed] [Google Scholar]
- 19.Dhein S. Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res. 2004;62:287–298. doi: 10.1016/j.cardiores.2004.01.019. [DOI] [PubMed] [Google Scholar]
- 20.Bai D, del Corsso C, Srinivas M, Spray DC. Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB) J Pharmacol Exp Ther. 2006;319:1452–1458. doi: 10.1124/jpet.106.112045. [DOI] [PubMed] [Google Scholar]
- 21.Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, Peppiatt CM. 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J. 2002;16:1145–1150. doi: 10.1096/fj.02-0037rev. [DOI] [PubMed] [Google Scholar]
- 22.Snetkov VA, Aaronson PI, Ward JP, Knock GA, Robertson TP. Capacitative calcium entry as a pulmonary specific vasoconstrictor mechanism in small muscular arteries of the rat. Br J Pharmacol. 2003;140:97–106. doi: 10.1038/sj.bjp.0705408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Robertson TP, Aaronson PI, Ward JP. Hypoxic vasoconstriction and intracellular Ca2+ in pulmonary arteries: evidence for PKC-independent Ca2+ sensitization. Am J Physiol Heart Circ Physiol. 1995;268:H301–H307. doi: 10.1152/ajpheart.1995.268.1.H301. [DOI] [PubMed] [Google Scholar]
- 24.Ward JP, McMurtry IF. Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol. 2009;9:287–296. doi: 10.1016/j.coph.2009.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V, et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol. 2006;570:53–58. doi: 10.1113/jphysiol.2005.098855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Strielkov IV, Khromov AS. Hypoxic pulmonary hypertension: The role of phosphatidylcholine-specific phospholipase C. Int J Phys Pathophys. 2010;1:119–124. [PubMed] [Google Scholar]
- 27.Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, et al. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci USA. 2006;103:19093–19098. doi: 10.1073/pnas.0606728103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Talbot NP, Balanos GM, Dorrington KL, Robbins PA. Two temporal components within the human pulmonary vascular response to approximately 2 h of isocapnic hypoxia. J Appl Physiol. 2005;98:1125–1139. doi: 10.1152/japplphysiol.00903.2004. [DOI] [PubMed] [Google Scholar]
- 29.Manoury B, Etheridge SL, Reid J, Gurney AM. Organ culture mimics the effects of hypoxia on membrane potential, K(+) channels and vessel tone in pulmonary artery. Br J Pharmacol. 2009;158:848–861. doi: 10.1111/j.1476-5381.2009.00353.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Christ GJ. Modulation of alpha 1-adrenergic contractility in isolated vascular tissues by heptanol: a functional demonstration of the potential importance of intercellular communication to vascular response generation. Life Sci. 1995;56:709–721. doi: 10.1016/0024-3205(95)00001-m. [DOI] [PubMed] [Google Scholar]
- 31.Lagaud G, Davies KP, Venkateswarlu K, Christ GJ. The physiology, pathophysiology and therapeutic potential of gap junctions in smooth muscle. Curr Drug Targets. 2002;3:427–440. doi: 10.2174/1389450023347399. [DOI] [PubMed] [Google Scholar]
- 32.Earley S, Resta TC, Walker BR. Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries. Am J Physiol Heart Circ Physiol. 2004;287:H2677–H2686. doi: 10.1152/ajpheart.00016.2004. [DOI] [PubMed] [Google Scholar]
- 33.McElroy SP, Gurney AM, Drummond RM. Pharmacological profile of store-operated Ca(2+) entry in intrapulmonary artery smooth muscle cells. Eur J Pharmacol. 2008;584:10–20. doi: 10.1016/j.ejphar.2008.01.018. [DOI] [PubMed] [Google Scholar]
- 34.Weigand L, Foxson J, Wang J, Shimoda LA, Sylvester JT. Inhibition of hypoxic pulmonary vasoconstriction by antagonists of store-operated Ca2+ and nonselective cation channels. Am J Physiol Lung Cell Mol Physiol. 2005;289:L5–L13. doi: 10.1152/ajplung.00044.2005. [DOI] [PubMed] [Google Scholar]
- 35.Contreras JE, Saez JC, Bukauskas FF, Bennett MV. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci USA. 2003;100:11388–11393. doi: 10.1073/pnas.1434298100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Takenaka T, Inoue T, Kanno Y, Okada H, Meaney KR, Hill CE, et al. Expression and role of connexins in the rat renal vasculature. Kidney Int. 2008;73:415–422. doi: 10.1038/sj.ki.5002673. [DOI] [PubMed] [Google Scholar]
- 37.Matchkov VV, Rahman A, Peng H, Nilsson H, Aalkjaer C. Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries. Br J Pharmacol. 2004;142:961–972. doi: 10.1038/sj.bjp.0705870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gaine SP, Hales MA, Flavahan NA. Hypoxic pulmonary endothelial cells release a diffusible contractile factor distinct from endothelin. Am J Physiol Lung Cell Mol Physiol. 1998;274:L657–664. doi: 10.1152/ajplung.1998.274.4.L657. [DOI] [PubMed] [Google Scholar]
- 39.Robertson TP, Ward JP, Aaronson PI. Hypoxia induces the release of a pulmonary-selective, Ca2+-sensitising, vasoconstrictor from the perfused rat lung. Cardiovasc Res. 2001;50:145–150. doi: 10.1016/s0008-6363(01)00192-4. [DOI] [PubMed] [Google Scholar]
- 40.Gairhe S, Bauer NN, Gebb SA, McMurtry IF. Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation. Am J Physiol Lung Cell Mol Physiol. 2012;303:L767–777. doi: 10.1152/ajplung.00183.2012. [DOI] [PubMed] [Google Scholar]
- 41.Guilluy C, Eddahibi S, Agard C, Guignabert C, Izikki M, Tu L, et al. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med. 2009;179:1151–1158. doi: 10.1164/rccm.200805-691OC. [DOI] [PubMed] [Google Scholar]
- 42.Waypa GB, Chandel NS, Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res. 2001;88:1259–1266. doi: 10.1161/hh1201.091960. [DOI] [PubMed] [Google Scholar]
- 43.Knock GA, Snetkov VA, Shaifta Y, Connolly M, Drndarski S, Noah A, et al. Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca2+ sensitization. Free Radic Biol Med. 2009;46:633–642. doi: 10.1016/j.freeradbiomed.2008.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chi AY, Waypa GB, Mungai PT, Schumacker PT. Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells. Antioxid Redox Signal. 2010;12:1–7. doi: 10.1089/ars.2009.2861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Fuchs B, Rupp M, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F, et al. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6. Respir Res. 2011;12:20. doi: 10.1186/1465-9921-12-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Strielkov IV, Ward JP, Aaronson PI. Evidence of phosphatidylcholine-specific phospholipase C involvement in hypoxic pulmonary vasoconstriction. Proc Physiol Soc. 2011;23:PC358. [Google Scholar]